Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Lastest Finance News

GlobalData buys job data provider LinkUp as part of 3-year growth plan

13th Nov 2024 09:31

(Alliance News) - GlobalData PLC on Wednesday said trading in the second half of its current financial year is in line with market expectations, and announced its acquisition of job market data provider LinkUp. Read More

TOP NEWS: Flutter upgrades guidance following strong third-quarter

13th Nov 2024 09:20

(Alliance News) - Flutter Entertainment PLC on Wednesday upgraded its full-year guidance amid strong revenue growth in the third quarter. Read More

LONDON MARKET OPEN: London stocks green as "Trump trade" wears off

13th Nov 2024 09:12

(Alliance News) - Stock prices in London opened higher on Wednesday morning, with market participants' eyes on a key US inflation reading due later. Read More

TOP NEWS: Experian interim profit falls amid interest rate movements

13th Nov 2024 08:58

(Alliance News) - Experian PLC on Wednesday said profit fell in the first six months of its current financial year despite revenue growth, as a result of adverse interest rate movements. Read More

TOP NEWS: SSE lifts dividend as renewable energy underpins profit rise

13th Nov 2024 08:55

(Alliance News) - SSE PLC on Wednesday said its long-serving chief executive will retire next year, as it posted a sharp rise in half-year profitability. Read More

CORRECT: Stocks called higher while Trump assembles cabinet

13th Nov 2024 08:41

(Corrects Babcock's half-year revenue from a year ago to GBP2.18 billion from GBP1.18 billion.) Read More

TOP NEWS: Smiths Group lifts outlook and upsizes share buyback

13th Nov 2024 08:40

(Alliance News) - Smiths Group PLC on Wednesday raised its outlook on the back of a strong start to its financial year, and the company increased its share buyback after opting against pursing an acquisition it had sized up. Read More

IN BRIEF: Schroders starts GBP20 million share buyback

13th Nov 2024 08:33

Schroders PLC - London-based asset and wealth manager - Starts share buyback worth up to GBP20 million on Wednesday. The buyback will be run by Barclays Bank PLC and be completed by the end of December. The repurchased shares will be held in treasury to meet awards under Schroders's employee share schemes, or otherwise will be cancelled to reduce capital. Read More

Thames Water deal reaches "important milestone" in creditor backing

13th Nov 2024 08:29

(Alliance News) - Thames Water Utilities Ltd has won support from three-quarters of its creditors for an emergency funding deal which would throw the struggling utility company a GBP3 billion lifeline. Read More

LONDON BRIEFING: Stocks called higher while Trump assembles cabinet

13th Nov 2024 07:55

(Alliance News) - London stocks were called to open in the green on Wednesday, while eurozone and Asian markets prepare themselves for tariffs from the hawkish incoming US government. Read More

TOP NEWS: Just Eat sells GrubHub for USD650 million

13th Nov 2024 07:17

(Alliance News) - Just Eat Takeaway.com NV on Wednesday revealed it has struck a deal to sell Grubhub Inc for USD650 million. Read More

LONDON MARKET EARLY CALL: FTSE 100 to rise as EU tensions simmer

13th Nov 2024 07:03

(Alliance News) - Stocks in London are set to open higher on Wednesday, ahead of a key US inflation reading and, and as unemployment data from France came in a notch higher. Read More

Alliance News UK - start of day

13th Nov 2024 06:30

(Alliance News) - Welcome to the Alliance News UK service (ISSN 2515-9453), consisting of the Alliance News UK Professional and its family of financial newswires serving investors and their professional advisers. Read More

IN BRIEF: Merck trial shows Koselugo effective in treating adults

12th Nov 2024 19:50

Merck & Co Inc and AstraZeneca PLC - Pharmaceutical companies based in Rahway, New Jersey and Cambridge, England, respectively - Phase 3 Komet trial shows statistically significant and clinically meaningful improvement in objective response rate in adult neurofibromatosis patients treated with AstraZeneca and Merck's joint-developed medication Koselugo. The condition is a rare progressive genetic disease in which tumours develop on nerve sheaths and may lead to disfigurement, motor dysfunction, pain, airway dysfunction, visual impairment and bladder or bowel dysfunction. Koselugo is approved to treat children with the disease but there is little intervention available for adults. Read More

LONDON MARKET CLOSE: Stocks slip and pound falls but dollar rides high

12th Nov 2024 17:06

(Alliance News) - London's FTSE 100 resumed its downward path on Tuesday, as a mixed bag of earnings, political uncertainty, and stronger-than-expected wage growth dented the mood. Read More

FTSE 100 Latest
Value8,275.92
Change-5.30